Related Experiment Videos
Inhibition of carcinogenesis by retinoids
Abstract:
Retinoids are effective inhibitors of chemical carcinogenesis in the mammary gland and urinary bladder of experimental animals. Modification of the basic retinoid structure has produced retinoids with increased target organ specificity, resulting in increased anticancer activity with reduced systemic toxicity. Combining retinoid treatment with hormonal manipulation results in a synergistic inhibition of mammary carcinogenesis; this combination approach also inhibits development of additional mammary cancers following surgical removal of the first mammary cancer. Retinoids are most effective when administered shortly after the carcinogenic insult. However, even when retinoid treatment is delayed, the compounds are still effective cancer chemopreventive agents for the mammary gland and urinary bladder. The length of time that retinoid exposure can be delayed and retain an anticancer effect is directly related to tumor latency, with a longer delay permissible against tumors with long latent periods.
Insights
Retinoids show promise in preventing mammary and urinary bladder cancers in animals. Modified retinoids offer targeted cancer prevention with fewer side effects, even when treatment is delayed.
Area of Science:
- Oncology
- Chemoprevention
- Carcinogenesis research
Background:
- Retinoids are established chemopreventive agents against chemical carcinogenesis.
- Experimental models demonstrate retinoid efficacy in mammary gland and urinary bladder cancer prevention.
- Modifications to retinoid structures enhance target organ specificity and reduce toxicity.
Purpose of the Study:
- To evaluate the efficacy of modified retinoids in cancer chemoprevention.
- To investigate the synergistic effects of retinoid treatment combined with hormonal manipulation.
- To determine the impact of delayed retinoid administration on chemopreventive activity.
Main Methods:
- Administration of modified retinoids to experimental animals.
- Combination therapy involving retinoids and hormonal manipulation.
- Assessment of cancer incidence and development following carcinogenic insult and varying treatment delays.
Main Results:
- Retinoids effectively inhibit mammary gland and urinary bladder carcinogenesis.
- Modified retinoids exhibit increased anticancer activity and reduced systemic toxicity.
- Combined retinoid and hormonal therapy synergistically inhibit mammary carcinogenesis.
- Retinoid treatment remains effective even when initiated after the carcinogenic insult, with efficacy duration linked to tumor latency.
Conclusions:
- Retinoids are potent chemopreventive agents for mammary and urinary bladder cancers.
- Structural modifications and combination therapies enhance retinoid efficacy and safety.
- Delayed retinoid administration is a viable strategy for cancer chemoprevention, particularly for tumors with long latency periods.